re timing of the expansion that was dealt with just weeks

New Post Public Reply Private Reply Replies (1) Message Board
microcaps
960
re timing of the expansion that was dealt with just weeks later in another update noted below and subsequent updates and posts
NNLX doesnt control the pps (except by avoiding the usual spiraling financing loan traps of poisonous financing) that sink penny startups or stock manipulators.
NNLX didnt guarantee the timeline - in the 1st update NNLX repeatedly said "expected" timeline- i.e if the expected financing methods came to fruition-but as mentioned ,as is often the case in the real world -esp the penny world-the expected financing conditions for the expected methods did not come to pass,even those methods were reasonable at the time announced.
We have all been surprised by unexpected conditions /mr murphy in our own lives which derailed expected timetables -that is even more true in the more complicated scenarios of penny stocks- i include some other discussion at the time
there are many sick entities,including many governmental entities from 2009 to date-waiting to pounce on pennystocks for any mistake,including fundraising mistake they make.

I dont remember exactly but i believe further discussion showed they had to change finance plans because of unexpected pps depreciation-but the bigger point is that the bashers (who are sometimes responsible for falling pps) who take these things out of context have the same info available to me or anyone,which gives them the same opportunity to give an honest analysis - not a skewed analysis which requires me or somebody else to do the dd to set the record straight




Posted On: 12/20/2016 2:16:22 PM

Posted By: LuckyDog111
Latest Email Update:
Nanologix Incorporated

NanoLogix is pleased to announce the following Update:

The Company has narrowed its selection of buildings to use as a larger production facility in northeast Ohio. Two existing buildings are now under consideration to house NanoLogix production for both petri plates and for production of the new N-Assay ELISA-based rapid bacteria diagnostic.

The projected expenditure for establishing N-Assay production and increasing petri plate production is roughly $900,000 for production equipment, $125,000 for the construction of two separate 70' X 30' production cleanrooms, and $40,000 for additional equipment such as forklifts.


​This expansion is projected to result in market share increase for petri plate sales due to markedly improved economies of scale, and position NanoLogix with a significant production capability for the new N-Assay modified ELISA comprehensive bacteria diagnostic kit. The Company expects the expansion will result in ten additional jobs starting with the delivery and setup of the production equipment in 2017 and another ten positions upon expansion of N-Assay sales.

​Over the coming six months we expect to finance the expansion through a combination of increasing revenue from sales of both product lines and fundraising through our current SEC Regulation D, Rule 506 offering for private placement sales of shares.

Any share issuance financing for this expansion is being structured primarily, but not solely, through a series of equity tranches and stock warrants
. Using this method, the Company hopes to keep stock dilution to a minimum and will proceed with the interests of the shareholders in mind, including extending the timeline for expansion as necessary if equity costs are not favorable to NanoLogix.

​The Company is preparing to seek licensees in Europe and Hong Kong for production of FlatPack Petri Plates under the recent EU FlatPack patent approval.

In response to queries coming to our office regarding our customization of the N-Assay for a multibillion medical technology company: we have sold 600+ of the N-Assay to them and will be supplying more in addition to further customization for other bacteria in 2017. As our arrangement with the client is CONFIDENTIAL, we will not be releasing their name.
​Merry Christmas from Carol, Debby, Kim, Travis, Bret and all







Posted On: 12/08/2016 10:36:23 PM
Avatar
Posted By: microcaps
we just go aro8ind in circles with the same naysayers keep bringing up the same arguments

re lack of current financials-some comments

due to financial exigencies and other reasons the majority of public otc companies do NOT have current financials-so NNLX is in the majority there
ca 900 OTCQB co's, sometimes 10000 grey co's, 1000's of no info co's and probably 1000's of limited info co's plus 500 or more skull and bones- otc used to post numbers for each but i havent seen lately
so whereas i'd like to see financials as one of my undergraduate degrees was accounting, i'm just putting this into perspective

of course financials are great for public co's to report but due to said financial exigencies at critical times co's fail to keep reported financials current-this includes many sec reporting co's who thus are relegated to limited info or no info status themselves til they catch up- i'm in 2 of those right now

it cost 10000/yr for otc OTCQB reporting status,4200 for pink current,and years ago a CEO told me otc was charging them 3000/yr for limited info news disclosure service-for these low pennies that can be a lot of money at critical junctures

even when financials are posted- and i've literally looked at thousands of pennies financials- based on the standards we were taught there financials usually look like disasters-thats why pps is pennies and not 50000 times higher!!!!!!

the point and relevancy for such co's is the direction they are taking-is their movement/progress-despite my penchant for financials that movement is far more important than current financials for such a development stage co

when my best friends construction co folded due to the great recession, in desperation he got into pennies and made a 40 fold return in 6 months, thus finally dragging me in-but as i quickly looked at the financials of the co's he was trading i was shocked
and told him these co's are bankrupt!!!!
he didnt care and neither did the pps because in these development stage co's other things were more important

many penny co's dont even have a product and many who do dont have the means to bring such to fruition-that kind of thing is more important at this stage

Posted On: 12/09/2016 11:26:28 AM

Posted By: kcheung
We (all my retired friends & I ) are confident that a tiny co with minimal

external debt and a "disruptive" technology in a multi-billion ; rapidly growing

and important market occupied by "big boys" will take some time to crack the

market. Obviously IMO NNLX major share-holders do not want

NNLX to be owned/taken over; but going on her own road of development. A

small business owner for four decades, I fully understand and respect this.

A pa & mom investor in the market, have seen so many brilliant tech co

ruined and swallowed because of heavy external debts. Glad BB steered the

ship with strong and stead hands. Our hats off to him and the management !

(most of our retired friends were small business owners and know how

difficult to survive in today's tough business world.)

Posted On: 12/09/2016 12:49:05 PM Replies (0)

Posted By: mitstevfel #2779
Re: Drekab #2776
Drekab,

Through the grapevine, I heard there were at the least two companies that responded for initial talks with NNLX --- Roche Diagnostics and Emergent BioSolutions. Then the crisis ended. In the below press release, NNLX did state they didn't have the necessary resources to develop the test independently. Level Four Research facilities (BSL-4), necessary for working with hemorrhagic fever viruses, don't come cheap.

As for ZIKA, there's no advantage to finding it in 6 hours versus 2 weeks --- it's not an immediate life threat.

This was a press release from 10/14/14:

"HUBBARD, Ohio--(BUSINESS WIRE)--NanoLogix Inc. (NNLX), an innovative biotechnology company in Northeastern Ohio announces that it is configuring its N-Assay Rapid diagnostic kits for both Ebola Virus and Enterovirus detection and identification. NanoLogix CEO Bret Barnhizer stated, “The Company has been aware of the virus detection capabilities of the technology since the N-Assay development. Viruses viewed as public health concerns prior to Ebola and Enterovirus were Influenza, the common cold, and HIV, none of which have an immediate or near-immediate threat of mortality. Until recently, NanoLogix has been focused solely on the use of their N-Assay kit for bacteria detection and identification. Now, with the recent outbreaks of both Ebola and Enterovirus there is an immediate need for configuration of the N-Assay for viruses. NanoLogix facilities are not designed for work on viruses, for this specific project we are seeking a corporate partner with the facilities necessary to bring the new N-Assay (V) to the market as quickly as possible. We consider this a matter of national security and an emergency priority. We are in discussions with potential partners, positioned with strong ties to the US government, who understand the serious threat these viruses represent.”


Scott
Posted On: 12/09/2016 12:47:37 PM

Posted By: Kachingpdx1
More info to read over the weekend. Again, knowledge is power.

http://shareholdersunite.com/the-ioc-files-us...-shorting/


Posted On: 12/10/2016 4:13:46 PM Replies (1)
Avatar
Posted By: microcaps #2788
Re: Kachingpdx1 #2778
very nice summary-the info from the article below explains why brokers are continually blatantly violating their fiduciary duty to retail longs by persistently restricting without warning and then shorting thousands of pennys in a massive hybrid public/ private eminent domain taking against innocent 3rd party purchasers (retail longs) with immunity, -especially since 2009-all of this is blatantly illegal/unconstitutional and would never be allowed outside of the stock world despite the massive corruption of the legal system itself

I dont know whats better-the present admin policy: "business is evil and has to be stopped but I have no power to stop big business, so I'm going to destroy these defenseless pennies (because they have no political or legal clout to defend themselves) or having Goldman Sachs running cabinet departments, as you have mentioned

and yes, hedge funds and other animals do short pennies down to .0001 w the aid of brokers violation of fiduciary duty-only in the stock market -a massive reverse robinhood scheme.

i do beg to differ w 1 point in the article - discount brokers have added millions of traders and and scores of millions of more trades, all w commissions to line brokers pockets -this electronic trading only costs brokers ca 8c/trade(i forgot the exact average figure)

DTCC- 1of the most shadowy agencies you can find-despite thousands of pages of expose re their unconstitutional manipulation-how its owned by the brokers is an amazing long story of political etc fraud-

from the article:

Prime brokers allow their hedge fund customers leverage on their assets, meaning that for every dollar of asset, they could easily hold $10 of short positions.
This over-leverage presents a systemic risk should positions in several larger funds go the wrong way, as there isn’t enough collateral to cover the domino effect of multiple positions being forced to cover.
This over-leverage creates an environment where the brokers are now pregnant with their hedge fund customers’ liabilities, and have a vested interest in seeing depressed stock prices remain depressed – if the stocks go up, the hedge funds could easily fail, and the brokers are on the hook to buy-in and deliver the stock owed by the funds – resulting in brokerage failures.
The DTCC is ultimately at risk for this domino effect, as brokerages fail.
The DTCC is owned by the brokers, thus is the brokers.
The DTCC processes over $1.2 quadrillion (million trillion) every year, and owns most of the stock American investors hold in their accounts – but most of the country has never heard of the company
(0) (0)

Nanologix Inc (NNLX) Stock Research Links

NNLX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading

Top 5 Most Recently Viewed Articles

How a $100 Investment in Casey's General Stores Grew

Updated Category News Views 183

Understanding the Growth of Casey's General Stores Casey's General Stores (NASDAQ: CASY) has notably outperformed the market over the last decade. Investors have been delighted with an annualized return of approximately 16.93%, surpassing the market by 4.4%. A remarkable market capitalization of $19.79 billion reflects the company's robust position within the retail...

Continue Reading
THEON's 2024 Results Show Strong Growth and Future Potential

Updated Category News Views 394

THEON's Strong FY 2024 Performance Surpasses Expectations THEON International Plc, listed on Euronext Amsterdam as (THEON), has released its preliminary financial results for FY 2024, illustrating a remarkable performance throughout the year. With a solid strategy in place, the company not only met but exceeded its revenue guidance, showcasing its robust business model...

Continue Reading
Important Class Action Information for Ultra Clean Investors

Updated Category News Views 241

Essential Class Action Information for Investors In recent developments, Robbins LLP emphasizes the importance for stockholders of Ultra Clean Holdings, Inc. (NASDAQ: UCTT) who may have faced significant financial losses due to misleading company statements. The class action suits have been filed to protect investors who acquired securities within a specific time frame....

Continue Reading
Sable Resources Secures Additional $5 Million for Exploration

Updated Category News Views 206

Sable Resources Secures Additional $5 Million for Exploration VANCOUVER, British Columbia — Sable Resources Ltd. (TSXV:SAE | OTCQB:SBLRF) has officially announced a significant financial development. The company has received a $5 million payment from OR Royalties Inc. This payment is tied to the royalty agreement regarding TDG Gold Corp. which Sable sold to OR. This...

Continue Reading